HomeCAPR • NASDAQ
Capricor Therapeutics Inc
add
In the news
Stock Titan
1 day ago
Promising DMD Treatment Update: Capricor CEO Reveals Latest Development
Progress
2.26%
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 11.13M | -7.92% |
Operating expense | 4.27M | 24.62% |
Net income | -7.12M | -833.83% |
Net profit margin | -63.94 | -914.92% |
Earnings per share | -0.16 | -540.00% |
EBITDA | -7.32M | -652.00% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 151.52M | 283.70% |
Total assets | 170.48M | 190.26% |
Total liabilities | 25.02M | -30.76% |
Total equity | 145.46M | — |
Shares outstanding | 45.68M | — |
Price to book | 2.97 | — |
Return on assets | -14.61% | — |
Return on capital | -17.75% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -7.12M | -833.83% |
Cash from operations | -14.80M | -27.62% |
Cash from investing | -123.38M | -2,004.53% |
Cash from financing | 81.09M | 250.01% |
Net change in cash | -57.09M | -1,099.80% |
Free cash flow | -13.42M | -17.73% |
Previous close
$9.48
Day range
$9.21 - $9.93
Year range
$3.52 - $23.40
Market cap
432.78M USD
Avg Volume
1.56M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
CEO
Founded
2005
Website
Employees
160
